about
Advances in understanding benzene health effects and susceptibilityChemotherapeutic compounds targeting the DNA double-strand break repair pathways: the good, the bad, and the promisingCurrent understanding of lifestyle and environmental factors and risk of non-hodgkin lymphoma: an epidemiological updateRisk of non-Hodgkin lymphoma after radiotherapy for solid cancersIncidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study.Link between DNA damage and centriole disengagement/reduplication in untransformed human cells.Second malignancies in Hodgkin's disease: A review of the literature and report of a case with a secondary Lennert's lymphomaChemotherapy induced microsatellite instability and loss of heterozygosity in chromosomes 2, 5, 10, and 17 in solid tumor patients.Evaluation of oxaliplatin exposure of healthcare workers during heated intraperitoneal perioperative chemotherapy (HIPEC).Molecular investigation of coexistent chronic myeloid leukaemia and peripheral T-cell lymphoma - a case reportSecondary B-cell lymphoma diagnosed by fine-needle aspiration cytology and flow cytometry following penile carcinoma: A case report.Risk of other cancers in individuals with a family history of pancreas cancerSecond primary malignancy risk among patients with gastric cancer: a nationwide population-based study in Taiwan.Long-term survival of patients diagnosed with non-Hodgkin lymphoma after a previous malignancy.Cancer incidence among Swedish pulp and paper mill workers: a cohort study of sulphate and sulphite mills.Evaluation of DNA damage induced by norcantharidin in human cultured lymphocytes.Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi.
P2860
Q22255602-B3B8A874-5557-4029-BC86-3DFC9CFE43F7Q26863501-02C5A25D-D5BE-4700-9947-92E9802E8F34Q28388876-2C686C64-7C25-423B-8EF1-E0EE72F450AAQ28392833-29492ACA-7399-4385-989B-F26C910F1B45Q33651611-026CF064-5931-4059-AD65-DC2CBA7CC460Q34004317-B7BD373E-6E09-46B5-8A58-7DFA0B07534CQ34412940-A5D46137-62D5-4268-8012-99985CDE39C5Q34659119-3204311D-687B-4C59-A420-FB78D6AEA7D8Q35091204-A79317A4-82B0-4269-A19B-A41A6A0F5C61Q36123511-AF7A9DEE-EFBB-45D8-9A41-F8BD9C2B8F9EQ36742229-51A93B0D-F21C-4AED-8B81-1ACA42AE26D4Q37284983-02C5F511-AECF-4D22-8547-37F120DC5D22Q41220627-7FA3015A-4AE3-4E4F-8B80-FA17C70F8AE4Q44576115-9B0CE213-78B8-4877-A5FB-6443DA4D9A45Q46412913-BC1CF396-7C7C-490A-8BDC-521143E4DBB5Q46634780-BDA7E111-73CB-4BA6-BBF9-A534B379A936Q52590685-D841B9DF-BD39-4A9F-8D4E-D0C5B4B40056
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Non-Hodgkin lymphoma secondary to cancer chemotherapy.
@ast
Non-Hodgkin lymphoma secondary to cancer chemotherapy.
@en
type
label
Non-Hodgkin lymphoma secondary to cancer chemotherapy.
@ast
Non-Hodgkin lymphoma secondary to cancer chemotherapy.
@en
prefLabel
Non-Hodgkin lymphoma secondary to cancer chemotherapy.
@ast
Non-Hodgkin lymphoma secondary to cancer chemotherapy.
@en
P1476
Non-Hodgkin lymphoma secondary to cancer chemotherapy.
@en
P2093
Biju Krishnan
Gareth J Morgan
P304
P356
10.1158/1055-9965.EPI-06-1069
P577
2007-03-01T00:00:00Z